Traditional and complementary medicine (TCM) is playing an increasingly significant role in healthcare, as more people turn to it as an alternative or supplement to biomedicines. Herbs have been the basis of many biomedicines and continue to be a potential source of new medicines and dietary supplements.
The Health Innovations Research Institute's TCM Program features four multidisciplinary research groups, each with an excellent international reputation for using modern scientific methods to evaluate the quality, efficacy and safety of TCM. Its research focuses on major health concerns, including diabetes, pulmonary disease and pain management.
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Danshen (Salvia miltiorrhiza).
Tanshinone IIA is a derivative of phenanthrene-quinone isolated from Danshen. 
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